Xiangtao Li

Prof. Xiangtao Li


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2022 in Briefings in Bioinformatics
Verified
Journal Article
Closed access
PDF file
LHLei Huang
Lei Huang
JLJiecong Lin
Jiecong Lin
RLRui Liu
Rui Liu
ZZZetian Zheng
Zetian Zheng
LMLingkuan Meng
Lingkuan Meng
Ka-Chun WongKa-Chun Wong
Ka-Chun Wong
The identification of drug–target interactions (DTIs) plays a vital role for in silico drug discovery, in which the drug is the chemical molecule, and the target is the protein residues in the binding pocket. Manual DTI annotation approaches remain reliable; however, it is notoriously laborious and time-consuming to test each drug–target pair exhaustively. Recently, the rapid growth of labelled DTI data has catalysed interests in high-throughput DTI prediction. Unfortunately, those methods highly rely on the manual features denoted by human, leading to errors. Here, we developed an end-to-end deep learning framework called CoaDTI to significantly improve the efficiency and interpretability of drug target annotation. CoaDTI incorporates the Co-attention mechanism to model the interaction information from the drug modality and protein modality. In particular, CoaDTI incorporates transformer to learn the protein representations from raw amino acid sequences, and GraphSage to extract the molecule graph features from SMILES. Furthermore, we proposed to employ the transfer learning strategy to encode protein features by pre-trained transformer to address the issue of scarce labelled data. The experimental results demonstrate that CoaDTI achieves competitive performance on three public datasets compared with state-of-the-art models. In addition, the transfer learning strategy further boosts the performance to an unprecedented level. The extended study reveals that CoaDTI can identify novel DTIs such as reactions between candidate drugs and severe acute respiratory syndrome coronavirus 2-associated proteins. The visualization of co-attention scores can illustrate the interpretability of our model for mechanistic insights. Source code are publicly available at https://github.com/Layne-Huang/CoaDTI.

30 October 2020 in Briefings in Bioinformatics
Verified
Journal Article
Closed access
PDF file
YYYuning Yang
Yuning Yang
ZHZilong Hou
Zilong Hou
ZMZhiqiang Ma
Zhiqiang Ma
XLXiangtao Li
Xiangtao Li
Ka-Chun WongKa-Chun Wong
Ka-Chun Wong
Circular RNAs (circRNAs) are widely expressed in eukaryotes. The genome-wide interactions between circRNAs and RNA-binding proteins (RBPs) can be probed from cross-linking immunoprecipitation with sequencing data. Therefore, computational methods have been developed for identifying RBP binding sites on circRNAs. Unfortunately, those computational methods often suffer from the low discriminative power of feature representations, numerical instability and poor scalability. To address those limitations, we propose a novel computational method called iCircRBP-DHN using deep hierarchical network for discriminating circRNA-RBP binding sites. The network architecture can be regarded as a deep multi-scale residual network followed by bidirectional gated recurrent units (BiGRUs) with the self-attention mechanism, which can simultaneously extract local and global contextual information. Meanwhile, we propose novel encoding schemes by integrating CircRNA2Vec and the K-tuple nucleotide frequency pattern to represent different degrees of nucleotide dependencies. To validate the effectiveness of our proposed iCircRBP-DHN, we compared its performance with other computational methods on 37 circRNAs datasets and 31 linear RNAs datasets, respectively. The experimental results reveal that iCircRBP-DHN can achieve superior performance over those state-of-the-art algorithms. Moreover, we perform motif analysis on circRNAs bound by those different RBPs, demonstrating that our proposed CircRNA2Vec encoding scheme can be promising. The iCircRBP-DHN method is made available at https://github.com/houzl3416/iCircRBP-DHN.

25 January 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
ZYZhuohan Yu
Zhuohan Yu
YSYanchi Su
Yanchi Su
YLYifu Lu
Yifu Lu
YYYuning Yang
Yuning Yang
FWFuzhou Wang
Fuzhou Wang
XLXiangtao Li
Xiangtao Li
Single-cell RNA sequencing provides high-throughput gene expression information to explore cellular heterogeneity at the individual cell level. A major challenge in characterizing high-throughput gene expression data arises from challenges related to dimensionality, and the prevalence of dropout events. To address these concerns, we develop a deep graph learning method, scMGCA, for single-cell data analysis. scMGCA is based on a graph-embedding autoencoder that simultaneously learns cell-cell topology representation and cluster assignments. We show that scMGCA is accurate and effective for cell segregation and batch effect correction, outperforming other state-of-the-art models across multiple platforms. In addition, we perform genomic interpretation on the key compressed transcriptomic space of the graph-embedding autoencoder to demonstrate the underlying gene regulation mechanism. We demonstrate that in a pancreatic ductal adenocarcinoma dataset, scMGCA successfully provides annotations on the specific cell types and reveals differential gene expression levels across multiple tumor-associated and cell signalling pathways.

19 January 2023 in Communications Biology
Verified
Journal Article
Open access
PDF file
ZHZilong Hou
Zilong Hou
YYYuning Yang
Yuning Yang
ZMZhiqiang Ma
Zhiqiang Ma
Ka-Chun WongKa-Chun Wong
Ka-Chun Wong
XLXiangtao Li
Xiangtao Li
Protein-protein interactions (PPIs) govern cellular pathways and processes, by significantly influencing the functional expression of proteins. Therefore, accurate identification of protein-protein interaction binding sites has become a key step in the functional analysis of proteins. However, since most computational methods are designed based on biological features, there are no available protein language models to directly encode amino acid sequences into distributed vector representations to model their characteristics for protein-protein binding events. Moreover, the number of experimentally detected protein interaction sites is much smaller than that of protein-protein interactions or protein sites in protein complexes, resulting in unbalanced data sets that leave room for improvement in their performance. To address these problems, we develop an ensemble deep learning model (EDLM)-based protein-protein interaction (PPI) site identification method (EDLMPPI). Evaluation results show that EDLMPPI outperforms state-of-the-art techniques including several PPI site prediction models on three widely-used benchmark datasets including Dset_448, Dset_72, and Dset_164, which demonstrated that EDLMPPI is superior to those PPI site prediction models by nearly 10% in terms of average precision. In addition, the biological and interpretable analyses provide new insights into protein binding site identification and characterization mechanisms from different perspectives. The EDLMPPI webserver is available at http://www.edlmppi.top:5002/.

2 April 2018 in IEEE Transactions on Cybernetics
Verified
Journal Article
Closed access
XLXiangtao Li
Xiangtao Li
Ka-Chun WongKa-Chun Wong
Ka-Chun Wong
Patient stratification has a major role in enabling efficient and personalized medicine. An important task in patient stratification is to discover disease subtypes for effective treatment. To achieve this goal, the research on clustering algorithms for patient stratification has brought attention from both academia and medical community over the past decades. However, existing clustering algorithms suffer from realistic restrictions such as experimental noises, high dimensionality, and poor interpretability. In particular, the existing clustering algorithms usually determine clustering quality using only one internal evaluation function. Unfortunately, it is obvious that one internal evaluation function is hard to be fitted and robust for all datasets. Therefore, in this paper, a novel multiobjective framework called multiobjective clustering algorithm by fast search and find of density peaks is proposed to address those limitations altogether. In the proposed framework, a parameter candidate population is evolved under multiple objectives to select features and evaluate clustering densities automatically. To guide the multiobjective evolution, five cluster validity indices including compactness, separation, Calinski-Harabasz index, Davies-Bouldin index, and Dunn index, are chosen as the objective functions, capturing multiple characteristics of the evolving clusters. Multiobjective differential evolution algorithm based on decomposition is adopted to optimize those five objective functions simultaneously. To demonstrate its effectiveness, extensive experiments have been conducted, comparing the proposed algorithm with 45 algorithms including nine state-of-the-art clustering algorithms, five multiobjective evolutionary algorithms, and 31 baseline algorithms under different objective subsets on 94 datasets featuring 35 real patient stratification datasets, 55 synthetic datasets based on a real human transcription regulation network model, and four other medical datasets. The numerical results reveal that the proposed algorithm can achieve better or competitive solutions than the others. Besides, time complexity analysis, convergence analysis, and parameter analysis are conducted to demonstrate the robustness of the proposed algorithm from different perspectives.

10 February 2023 in Advanced Science
Verified
Journal Article
Open access
ZZZetian Zheng
Zetian Zheng
JCJunyi Chen
Junyi Chen
XCXingjian Chen
Xingjian Chen
LHLei Huang
Lei Huang
WXWeidun Xie
Weidun Xie
Ka-Chun WongKa-Chun Wong
Ka-Chun Wong
The single‐cell RNA sequencing (scRNA‐seq) quantifies the gene expression of individual cells, while the bulk RNA sequencing (bulk RNA‐seq) characterizes the mixed transcriptome of cells. The inference of drug sensitivities for individual cells can provide new insights to understand the mechanism of anti‐cancer response heterogeneity and drug resistance at the cellular resolution. However, pharmacogenomic information related to their corresponding scRNA‐Seq is often limited. Therefore, a transfer learning model is proposed to infer the drug sensitivities at single‐cell level. This framework learns bulk transcriptome profiles and pharmacogenomics information from population cell lines in a large public dataset and transfers the knowledge to infer drug efficacy of individual cells. The results suggest that it is suitable to learn knowledge from pre‐clinical cell lines to infer pre‐existing cell subpopulations with different drug sensitivities prior to drug exposure. In addition, the model offers a new perspective on drug combinations. It is observed that drug‐resistant subpopulation can be sensitive to other drugs (e.g., a subset of JHU006 is Vorinostat‐resistant while Gefitinib‐sensitive); such finding corroborates the previously reported drug combination (Gefitinib + Vorinostat) strategy in several cancer types. The identified drug sensitivity biomarkers reveal insights into the tumor heterogeneity and treatment at cellular resolution.